Have your own idea? Try our Stock Screener
The Clinical Research and Equipment industry is up 1.5% in the last week, with WuXi XDC Cayman up 9.9%. This means that the industry has gained 73% over the past year. As for the next few years, earnings are expected to grow by 33% per annum.
Has the Hong Kong Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 24 Mar 2025 | HK$217.0b | HK$32.6b | -HK$203,413,550.89 | 47.8x | -1066.9x | 6.6x |
Wed, 19 Feb 2025 | HK$195.8b | HK$35.8b | -HK$1,058,538,751.45 | 61.4x | -184.9x | 5.5x |
Fri, 17 Jan 2025 | HK$151.1b | HK$35.6b | -HK$1,062,252,938.54 | 56.1x | -142.3x | 4.2x |
Sun, 15 Dec 2024 | HK$154.0b | HK$35.8b | -HK$1,058,466,824.67 | 58.8x | -145.5x | 4.3x |
Tue, 12 Nov 2024 | HK$151.9b | HK$36.1b | -HK$1,055,366,091.19 | 44x | -143.9x | 4.2x |
Thu, 10 Oct 2024 | HK$165.6b | HK$35.9b | -HK$655,249,294.09 | 30.7x | -252.7x | 4.6x |
Sat, 07 Sep 2024 | HK$149.5b | HK$35.9b | -HK$658,597,307.62 | 23.4x | -227x | 4.2x |
Mon, 05 Aug 2024 | HK$97.0b | HK$33.8b | HK$3.1b | 19.4x | 31x | 2.9x |
Wed, 03 Jul 2024 | HK$87.7b | HK$33.4b | HK$3.1b | 17.5x | 28.5x | 2.6x |
Fri, 31 May 2024 | HK$90.1b | HK$33.6b | HK$3.1b | 28x | 29.1x | 2.7x |
Sun, 28 Apr 2024 | HK$108.0b | HK$33.6b | HK$3.1b | 30.6x | 34.9x | 3.2x |
Tue, 26 Mar 2024 | HK$116.3b | HK$33.2b | HK$3.7b | 52.7x | 31.7x | 3.5x |
Thu, 22 Feb 2024 | HK$134.2b | HK$32.3b | HK$3.0b | 56.8x | 45.1x | 4.2x |
Sat, 20 Jan 2024 | HK$197.8b | HK$32.5b | HK$3.0b | 85.7x | 65.4x | 6.1x |
Mon, 18 Dec 2023 | HK$212.6b | HK$32.5b | HK$3.0b | 85.2x | 70.5x | 6.5x |
Wed, 15 Nov 2023 | HK$261.0b | HK$30.1b | HK$2.7b | 45.7x | 97.6x | 8.7x |
Fri, 13 Oct 2023 | HK$265.0b | HK$30.1b | HK$2.7b | 47.4x | 99.1x | 8.8x |
Sun, 10 Sep 2023 | HK$223.8b | HK$30.1b | HK$2.7b | 40.1x | 84.3x | 7.4x |
Tue, 08 Aug 2023 | HK$235.8b | HK$28.4b | HK$2.7b | 22x | 86.5x | 8.3x |
Thu, 06 Jul 2023 | HK$209.8b | HK$28.3b | HK$2.7b | 20.6x | 77.7x | 7.4x |
Sat, 03 Jun 2023 | HK$235.5b | HK$28.9b | HK$2.8b | 20.9x | 83.6x | 8.1x |
Mon, 01 May 2023 | HK$249.3b | HK$29.5b | HK$2.9b | 24.5x | 85.3x | 8.5x |
Wed, 29 Mar 2023 | HK$251.7b | HK$28.9b | HK$2.5b | 23.3x | 102.7x | 8.7x |
Fri, 24 Feb 2023 | HK$288.4b | HK$26.3b | HK$2.1b | 25x | 140.5x | 11x |
Sun, 22 Jan 2023 | HK$371.2b | HK$26.6b | HK$2.1b | 27.8x | 174.2x | 14x |
Tue, 20 Dec 2022 | HK$267.0b | HK$25.9b | HK$2.0b | 24.8x | 134.7x | 10.3x |
Thu, 17 Nov 2022 | HK$285.7b | HK$25.8b | HK$1.9b | 26.9x | 146.9x | 11.1x |
Sat, 15 Oct 2022 | HK$258.7b | HK$25.6b | HK$1.9b | 21.3x | 138.5x | 10.1x |
Mon, 12 Sep 2022 | HK$343.4b | HK$26.3b | HK$2.0b | 25.7x | 168.7x | 13.1x |
Wed, 10 Aug 2022 | HK$389.2b | HK$22.3b | HK$2.0b | 12.1x | 190.4x | 17.5x |
Fri, 08 Jul 2022 | HK$431.2b | HK$22.4b | HK$2.1b | 14.5x | 207.8x | 19.3x |
Sun, 05 Jun 2022 | HK$299.3b | HK$22.5b | HK$2.1b | 13.1x | 142x | 13.3x |
Tue, 03 May 2022 | HK$312.2b | HK$22.7b | HK$2.2b | 14x | 145.1x | 13.8x |
Thu, 31 Mar 2022 | HK$360.8b | HK$23.3b | HK$2.4b | 17.4x | 153.5x | 15.5x |
153.5x
How does Hong Kong Clinical Research and Equipment compare with similar industries?
HK Market | -0.72% | |
Healthcare | 0.45% | |
Life Sciences | 1.51% | |
Clinical Research and Equipment | 1.51% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
2268 WuXi XDC Cayman | HK$42.10 | 4.9% +HK$2.3b | 133.9% | PE79.2x | |
1548 Genscript Biotech | HK$12.42 | 1.0% +HK$257.7m | -16.6% | PS5.8x | |
1873 Viva Biotech Holdings | HK$2.00 | 2.6% +HK$105.6m | 277.4% | PS2x | |
8225 China Health Group | HK$0.18 | 2.8% +HK$5.0m | 36.3% | PS6.9x |